These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21281948)

  • 21. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
    Van Schil PE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
    Mansour Z; Kochetkova EA; Santelmo N; Ducrocq X; Quoix E; Wihlm JM; Massard G
    Ann Thorac Surg; 2008 Jul; 86(1):228-33. PubMed ID: 18573428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
    Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer.
    Takamochi K; Oh S; Suzuki K
    Thorac Cardiovasc Surg; 2010 Sep; 58(6):345-9. PubMed ID: 20824587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
    Eberhardt W
    Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC.
    Steger V; Veit S; Walker T; Friedel G; Lehrach K; Mustafi M; Walles T
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):109-15. PubMed ID: 22821672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What is the value of neoadjuvant therapy in bronchial carcinoma?].
    Digel W; Brethner L; Hasse J
    Zentralbl Chir; 2000; 125(4):315-8. PubMed ID: 10829310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of smoking status on treatment outcomes after post-operative radiation therapy for non-small-cell lung cancer.
    Nguyen SK; Masson-Côté L; Fortin A; Dagnault A
    Radiother Oncol; 2010 Jul; 96(1):89-93. PubMed ID: 20541274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.
    Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G
    Radiother Oncol; 2010 Jul; 96(1):84-8. PubMed ID: 20541823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
    Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
    Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung cancer.
    Ng T; Birnbaum AE; Fontaine JP; Berz D; Safran HP; Dipetrillo TA
    Ann Surg Oncol; 2010 Feb; 17(2):476-82. PubMed ID: 19915918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.